Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02695381 · ClinicalTrials.gov registry record · Phase 3
Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness
A Phase 3 study, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT02695381 is a Phase 3 study that has completed, run by MEDRx USA. The registered enrollment target is 100 participants.
The verdict
NCT02695381, a Phase 3 study, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.
Interventions
- DRUG Placebo
- DRUG Etodolac-lidocaine topical patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02695381
The ClinicalTrials.gov registry entry for NCT02695381 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MEDRx USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02695381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02695381 about?
NCT02695381 is a clinical study titled "Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness". This study evaluate the efficacy and safety of Etodolac-lidocaine topical patch applied one time daily when compared with placebo in the treatment of acute Delayed Onset Muscle Soreness (DOMS) of the upper limbs.
What is the current status of trial NCT02695381?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2016-03. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02695381?
The interventions under investigation include: Placebo (DRUG), Etodolac-lidocaine topical patch (DRUG).
Who is sponsoring clinical trial NCT02695381?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.